Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
Open Access
- 8 July 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-17
Abstract
A large number of natural products have been advocated as anticancer agents. Many of these compounds contain functional groups characterized by chemical reactivity. It is not clear whether distinct mechanisms of action can be attributed to such compounds. We used a chemical library screening approach to demonstrate that a substantial fraction (~20%) of cytotoxic synthetic compounds containing Michael acceptor groups inhibit proteasome substrate processing and induce a cellular response characteristic of proteasome inhibition. Biochemical and structural analyses showed binding to and inhibition of proteasome-associated cysteine deubiquitinases, in particular ubiquitin specific peptidase 14 (USP14). The results suggested that compounds bind to a crevice close to the USP14 active site with modest affinity, followed by covalent binding. A subset of compounds was identified where cell death induction was closely associated with proteasome inhibition and that showed significant antineoplastic activity in a zebrafish embryo model. These findings suggest that proteasome inhibition is a relatively common mode of action by cytotoxic compounds containing Michael acceptor groups and help to explain previous reports on the antineoplastic effects of natural products containing such functional groups.Keywords
Funding Information
- Vetenskapsrådet (2018-02570)
- Cancerfonden (18-0702)
- Knut och Alice Wallenbergs Stiftelse (PR 0132)
- Radiumhemmets Forskningsfonder (184073)
- Barncancerfonden
This publication has 75 references indexed in Scilit:
- Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogsProceedings of the National Academy of Sciences, 2012
- Colloidal Aggregation Affects the Efficacy of Anticancer Drugs in Cell CultureACS Chemical Biology, 2012
- Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitorsTrends in Cell Biology, 2012
- Using the Heat-Shock Response To Discover Anticancer Compounds that Target Protein HomeostasisACS Chemical Biology, 2011
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic ProfilingJournal of Clinical Oncology, 2011
- Enhancement of proteasome activity by a small-molecule inhibitor of USP14Nature, 2010
- Focus on mammalian thioredoxin reductases — Important selenoproteins with versatile functionsBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation modelBMC Cancer, 2009
- GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene listsBMC Bioinformatics, 2009
- Relative Structural and Functional Roles of Multiple Deubiquitylating Proteins Associated with Mammalian 26S ProteasomeMolecular Biology of the Cell, 2008